Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials Academic Article uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Endpoint Determination
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms

abstract

  • 1) The median PFS from second complete remission is short. 2) A second response is rarely longer than the first even in this second CR population. 3) The number of patients with a second response longer than the first, or the proportion of patients remaining in complete remission at given time points could be evaluated as an outcome measure in future studies.

publication date

  • September 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2694792

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2007.05.008

PubMed ID

  • 17614127

Additional Document Info

start page

  • 469

end page

  • 75

volume

  • 106

number

  • 3